These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 398212

  • 21. [Reduction of left ventricular hypertrophy and increased tolerance to exertion in hypertensive patients after antihypertensive therapy with slow-release oxprenolol and chlorthalidone].
    Sau F, Seguro C, Alberti D, Cherchi A.
    Cardiologia; 1986 Sep; 31(9):701-8. PubMed ID: 2949838
    [No Abstract] [Full Text] [Related]

  • 22. [Comparative study of the hypotensive effect of a combination of oxprenolol-chlortalidone with single and fractionated administration].
    Rubegni M, Provvedi D, Bandinelli C, Bellini PG, De Mauro G.
    Boll Soc Ital Cardiol; 1976 Sep; 21(10):1853-8. PubMed ID: 1031614
    [No Abstract] [Full Text] [Related]

  • 23. Hydralazine and beta-adrenergic blockade in the treatment of hypertension.
    Siitonen L, Jänne J, Keyriläinen O, Koskinen P, Leskinen O, Pitkäjärvi T, Reinikainen M.
    Ann Clin Res; 1974 Dec; 6(6):341-6. PubMed ID: 4155933
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Effects of combined treatment with hydrochlorothiazide and oxprenolol on arterial pressure and activity of plasma renin. Preliminary results].
    Gysling E, de Wurstemberger B.
    Schweiz Med Wochenschr; 1974 Dec 07; 104(49):1797-8. PubMed ID: 4456598
    [No Abstract] [Full Text] [Related]

  • 26. Atenolol and chlorthalidone administered alone and in combination for essential hypertension.
    Boike SC, Durley Y, Cubberley RB.
    Clin Pharm; 1982 Dec 07; 1(5):449-53. PubMed ID: 6764166
    [No Abstract] [Full Text] [Related]

  • 27. [Treatment of hypertension with a combination of beta receptor blockers and diuretics (Trasitensin retard)].
    Mertz DP.
    MMW Munch Med Wochenschr; 1979 Feb 16; 121(7):251-2. PubMed ID: 105287
    [No Abstract] [Full Text] [Related]

  • 28. [Clinical trials with clonidine-chlorthalidone, a combined preparation in the treatment of hypertensive diseases].
    Dejaco RM, Hartl O.
    Wien Med Wochenschr; 1973 Feb 17; 123(7):96-9. PubMed ID: 4631628
    [No Abstract] [Full Text] [Related]

  • 29. Antihypertensive effect of oxprenolol and chlorthalidone in fixed combination, given once daily.
    Buoninconti R, Motolese M, Rubegni M.
    J Int Med Res; 1979 Feb 17; 7(6):519-23. PubMed ID: 391625
    [Abstract] [Full Text] [Related]

  • 30. One year efficacy and tolerability of oxprenolol slow-release and chlorthalidone on fixed combination in mild to moderate hypertension.
    Masoni A, Tomasi AM, Pirani R, Lazzaretto R, Ambroso G.
    G Ital Cardiol; 1981 Feb 17; 11(12):2105-9. PubMed ID: 7346306
    [Abstract] [Full Text] [Related]

  • 31. [Continuous 24-hour registration of intra-arterial pressure in basal states and during therapy with a fixed slow-release oxprenolol-chlorthalidone combination, administered once a day].
    Fariello R, Alicandri C, Boni E, Montini E, Zaninelli A, Agabiti-Rosei E, Motolese M, Muiesan G.
    G Ital Cardiol; 1984 Feb 17; 14(2):121-6. PubMed ID: 6714549
    [Abstract] [Full Text] [Related]

  • 32. Combined clonidine-chlorthalidone therapy in hypertension. Two years' experience in 30 patients.
    Rosenman RH.
    Arch Intern Med; 1975 Sep 17; 135(9):1236-9. PubMed ID: 1164125
    [Abstract] [Full Text] [Related]

  • 33. Effects of moderate salt restriction in hypertensive patients treated with oxprenolol or chlorthalidone.
    Pollavini G, Comi D, Grillo C, Lombardo M, Mantero O, Minetti L, Selvini A, Suppa G.
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug 17; 22(8):451-5. PubMed ID: 6490228
    [Abstract] [Full Text] [Related]

  • 34. Comparative anti-hypertensive effects of labetalol and the combination of oxprenolol and phentolamine.
    Johnson BF, LaBrooy J, Munro-Faure AD.
    Br J Clin Pharmacol; 1976 Aug 17; 3(4 Suppl 3):783-7. PubMed ID: 791332
    [Abstract] [Full Text] [Related]

  • 35. [Treatment of hypertension with the beta-receptor-antagonist pindolol (Viskèn). A comparison with chlorthalidone (Hygroton)].
    Schaffalitzky de Muckadel, Gyntelberg F.
    Ugeskr Laeger; 1973 May 17; 135(20):971-4. PubMed ID: 4585570
    [No Abstract] [Full Text] [Related]

  • 36. [Chlorthalidone at low doses in the treatment of mild to moderate essential hypertension in elderly patients].
    Armaganijan D, Sbissa AS, Savióli Neto F, Sbissa L, Batlouni M.
    Arq Bras Cardiol; 1988 Jun 17; 50(6):427-30. PubMed ID: 3073730
    [No Abstract] [Full Text] [Related]

  • 37. [Oxprenolol in the treatment of essential arterial hypertension].
    Soto Rojas G.
    Prensa Med Mex; 1976 Jun 17; 41(5-6):188-93. PubMed ID: 792867
    [No Abstract] [Full Text] [Related]

  • 38. Comparison of the antihypertensive effects of betaxolol and chlorthalidone as monotherapy and in combination.
    Burris JF, Davidov ME, Jenkins P, Rofman B, Ginsberg D, Rosenbaum R, Ryan JR, Jain AK, Mroczek WJ.
    Arch Intern Med; 1989 Nov 17; 149(11):2437-41. PubMed ID: 2684073
    [Abstract] [Full Text] [Related]

  • 39. [Atenolol-chlorthalidone combination vs placebo: controlled clinical trial in patients with medium-mild arterial hypertension].
    Campana C, Ferrario M, Tondi C, Montemartini C.
    Minerva Cardioangiol; 1985 Oct 17; 33(10):643-7. PubMed ID: 3908972
    [No Abstract] [Full Text] [Related]

  • 40. [Effectiveness of treatment with beta-blocking agents and diuretics in fixed combination, in aged hypertensive patients].
    Paciaroni E, Quattrini L, Saccomanno G, Andreoni A.
    G Ital Cardiol; 1980 Oct 17; 10(12):1737-41. PubMed ID: 6114010
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.